Title
Staphefekt™ by Micreos
Go Home
Category
Description
Staphefekt™ is the world's first product that selectively kills Staphyloccus aureus and MRSA.
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
Staphefekt™ by Micreos
Page Views
0
Share
Update Time
2022-10-25 04:30:32

"I love Staphefekt™ by Micreos"

www.staphefekt.com VS www.gqak.com

2022-10-25 04:30:32

(0) Log in Home Technology Products News & Publications Company Contact Staphefekt™Staphefekt™, developed by Micreos, is the world’s first endolysin available for human use on intact skin.Staphefekt™ specifically targetsStaphylococcus aureus, including strains that are resistant to antibiotics such as MRSA. Thanks to its bacterial specificity it leaves beneficial bacteria unharmed, which is especially important in case of longer term use. Staphefekt XDR.300 is an aseptic liquid solution. Micreos has also developed a series of creams and gels containing Staphefekt, for people with skin conditions with an infectious component, like acne, eczema, rosacea and skin irritation. These are available under theGladskinbrand.Endolysins are bacteria-killing enzymes that originate from bacteriophages (phages), the natural enemy of bacteria. Both have been around for billions of years. The Staphefekt endolysin exhibits two additional useful characteristics to combat bacterial infections: rapid killing of bacteria and very limited likelihood of emerging resistance.Context:New strategies for the treatment of bacterial infections are needed, as resistance is emerging against established antibiotics.Antibacterial resistance kills nearly fifty thousand people per year across the EU and USA whilst inducing healthcare costs of nearly £14 billion (WHO Antimicrobial Resistance Global Report on Surveillance 2014).There is no other targeted treatment for bacterial infections.Antibiotics killnot onlythe unwanted bacteria but also the beneficial ones living on and insideour body, and their use can cause side effects and induce the development of resistance.News & Publications Newsweek, Nov 13, 2014Revolutionary New Antibiotic Alternative Could Save ...Read moreThe Times, Nov 6, 2014Scientists create drug to replace antibiotics.Read moreMore newsHow it works Information Technology Products Research & Collaborations Media News & Publications About us Contact Company Privacy Policy Terms & Conditions Disclaimer Follow us LinkedIn Twitter Newsletter © 2022 Staphefekt™ by Micreos Human Health - All rights reserved - Powered by nopCommerce Stay informed Wait...